Total revenue from operations of the Hyderabad-headquartered generic drugmaker was lower at ₹7,546.4 crore (₹8,528.4 crore), according to the results prepared as per Indian Accounting Standards (Ind AS)
{"requested_language":"te","item":{"id":"67668c73-192c-449d-8554-54a52266faef","slug":"dr-reddys-q4-dips-86-on-lower-sales-multiple-one-offs-to-221-crore-67668c73","category":"top-stories","published_at":"2026-05-13T07:54:27Z","title":"Dr. Reddy’s Q4 dips 86% on lower sales, multiple one offs to ₹221 crore","summary":"Total revenue from operations of the Hyderabad-headquartered generic drugmaker was lower at ₹7,546.4 crore (₹8,528.4 crore), according to the results prepared as per Indian Accounting Standards (Ind AS)","source_url":"https://www.thehindu.com/business/Industry/dr-reddys-q4-dips-86-on-lower-sales-multiple-one-offs-to-221-crore/article70973283.ece","source_name":"www.thehindu.com","image_url":"https://th-i.thgim.com/public/incoming/p2fr2v/article70973253.ece/alternates/LANDSCAPE_1200/Dr.-Reddys-forGJ3FJU2IV.3.jpg.jpg","served_language":"en","is_fallback":true,"available_languages":["en"]}}